2022 Gilead Sciences Half-Year Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-?-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
2021 Mylan Mid-Year Review-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
US$ 750.00
June 2021
-
2018-2022 Animal Health: Market Segment Forecasts, and Leading Supplier Strategies, Marketing Tactics, and Technological Know-How
US$ 4,850.00
January 2018
110 pages
2019-2023 Animal Health Market Dynamics, Trends and Opportunities
US$ 2,450.00
April 2019
12 pages
2019 Pharmaceutical Competitive Intelligence: Pfizer Performance, Capabilities, Goals and Strategies
US$ 950.00
February 2019
-
